Hepatitis B vaccine - Intercell/SciGen
Alternative Names: HBV vaccine - Intercell/SciGen; Therapeutic hepatitis B vaccine - Intercell/SciGenLatest Information Update: 17 Dec 2021
At a glance
- Originator Intercell; SciGen
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 13 Nov 2006 Discontinued - Preclinical for Hepatitis B treatment in Austria (unspecified route)
- 13 Nov 2006 Discontinued - Preclinical for Hepatitis B treatment in Singapore (unspecified route)
- 13 Dec 2004 Preclinical trials in Hepatitis B treatment in Austria (unspecified route)